Serum IGF1, metabolic syndrome, and incident cardiovascular disease in older people: A population-based study

European Journal of Endocrinology

Volumn 168, Issue 3, 2013, Pages 393-401

  Van Bunderen, Christa C ^a   Oosterwerff, Mirjam M ^a   Van Schoor, Natasja M ^a   Deeg, Dorly J H ^a   Lips, Paul ^a   Drent, Madeleine L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NETHERLANDS; PHYSICAL ACTIVITY; POPULATION RISK; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SELF REPORT; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTRIGLYCERIDEMIA; INCIDENCE; INSULIN-LIKE GROWTH FACTOR I; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; SELF REPORT; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 84874034962     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0784     Document Type: Article

References (48)

1. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Hormone & IGF Research 2003 13 113-170. (doi:10.1016/S1096-6374(03)00038-8)
2. Conti E, Carrozza C, Capoluongo E., Volpe M, Crea F, Zuppi C & Andreotti F. Insulin-like growth factor-1 as a vascular protective factor. Circulation 2004 110 2260-2265. (doi:10.1161/01.CIR. 0000144309.87183.FB)
3. Janssen JA, Stolk RP, Pols H.A., Grobbee DE & Lamberts SW. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arteriosclerosis, Thrombosis, and Vascular Biology 1998 18 277-282. (doi:10.1161/01.ATV.18.2.277)
4. Johnsen SP, Hundborg HH, Sorensen H.T., Orskov H., Tjonneland A, Overvad K & Jorgensen JOL. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. Journal of Clinical Endocrinology and Metabolism 2005 90 5937-5941. (doi:10.1210/jc.2004-2088)
5. Juul A, Scheike T, Davidsen M., Gyllenborg J & Jorgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002 106 939-944. (doi:10.1161/01.CIR. 0000027563.44593.CC)
6. van Bunderen C.C., van Nieuwpoort IC, van Schoor NM, Deeg DJH, Lips P & Drent ML. The association of serum insulin-like growth factor-I with mortality, cardiovascular disease, and cancer in the elderly: a population-based study. Journal of Clinical Endocrinology and Metabolism 2010 95 4616-4624. (doi:10.1210/jc.2010-0940)
7. McNeill AM, Katz R, Girman C.J., Rosamond WD, Wagenknecht LE, Barzilay JI, Tracy R.P., Savage PJ & Jackson SA. Metabolic syndrome and cardiovascular disease in older people: the cardiovascular health study. Journal of the American Geriatrics Society 2006 54 1317-1324. (doi:10.1111/j.1532-5415. 2006.00862.x)
8. Butler J, Rodondi N, Zhu Y., Figaro K, Fazio S, Vaughan D.E., Satterfield S., Newman AB, Goodpaster B, Bauer DC et al. Metabolic syndrome and the risk of cardiovascular disease in older adults. Journal of the American College of Cardiology 2006 47 1595-1602. (doi:10.1016/j.jacc.2005.12.046)
9. Brugts MP, van Duijn CM, Hofland LJ, Witteman JC, Lamberts SWJ & Janssen JAMJ. Igf-I bioactivity in an elderly population: relation to insulin sensitivity, insulin levels, and the metabolic syndrome. Diabetes 2010 59 505-508. (doi:10.2337/db09-0583)
10. Yeap BB, Chubb SAP, Ho KKY, Setoh JWS, McCaul KA, Norman PE, Jamrozik K & Flicker L. IGF1 and its binding proteins 3 and 1 are differentially associated with metabolic syndrome in older men. European Journal of Endocrinology 2010 162 249-257. (doi:10.1530/EJE-09-0852)
11. Lam CSP, Chen MH, Lacey S.M., Yang Q., Sullivan LM, Xanthakis V, Safa R, Smith H.M., Peng X., Sawyer DB et al. Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 1479-1484. (doi:10.1161/ATVBAHA. 110.203943)
12. Saydah S, Ballard-Barbash R & Potischman N. Association of metabolic syndrome with insulin-like growth factors among adults in the US. Cancer Causes & Control 2009 20 1309-1316. (doi:10.1007/s10552-009-9351-x)
13. Sierra-Johnson J., Romero-Corral A, Somers V.K., Lopez-Jimenez F, Malarstig A, Brismar K., Hamsten A, Fisher RM & Hellenius ML. IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome. Clinical Science 2009 116 507-512. (doi:10.1042/CS20080382)
14. Parekh N, Roberts CB, Vadiveloo M, Puvananayagam T., Albu JB & Lu-Yao GL. Lifestyle, anthropometric, and obesity-related physiologic determinants of insulin-like growth factor-1 in the Third National Health and Nutrition Examination Survey (1988-1994). Annals of Epidemiology 2010 20 182-193. (doi:10.1016/j. annepidem.2009.11.008)
15. Deeg DJH, van Tilburg T, Smit JH & de Leeuw ED. Attrition in the Longitudinal Aging Study Amsterdam. The effect of differential inclusion in side studies. Journal of Clinical Epidemiology 2002 55 319-328. (doi:10.1016/S0895- 4356(01)00475-9)
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). Journal of the American Medical Association 2001 285 2486-2497. (doi:10.1001/jama.285.19.2486)
17. Dahlof B, Lindholm LH, Hansson L, Schersten B., Ekbom T & Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991 338 1281-1285. (doi:10.1016/0140-6736(91)92589- T)
18. Herdzik E, Safranow K & Ciechanowski K. Diagnostic value of fasting capillary glucose, fructosamine and glycosylated haemoglobin in detecting diabetes and other glucose tolerance abnormalities compared to oral glucose tolerance test. Acta Diabetologia 2002 39 15-22. (doi:10.1007/s005920200007)
19. Garretsen HFL. Probleemdrinken: prevalentiebepaling, beinvloedende factoren en preventiemogelijkheden. Theoretische overwegingen en onderzoek in Rotterdam. Lisse, 1983. PhD thesis submitted to Radboud University Nijmegen.
20. Clase CM, St Pierre MW & Churchill DN. Conversion between bromcresol green-and bromcresol purple-measured albumin in renal disease. Nephrology, Dialysis, Transplantation 2001 16 1925-1929. (doi:10.1093/ndt/16.9.1925)
21. Aiken LS, West SG & Reno RR. Multiple Regression: Testing and Interpreting Interactions. Ed McElroy S. California: Sage Publications, 1991.
22. Hypponen E, Boucher BJ, Berry DJ & Power C. 25-Hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008 57 298-305. (doi:10.2337/db07-1122)
23. Tong PCY, Ho CS, Yeung VTF, Ng MCY, So WY, Ozaki R, Ko GTC, Ma RCW, Poon E, Chan NN et al. Association of testosterone, insulin-like growth factor-I, and C-reactive protein with metabolic syndrome in Chinese middle-aged men with a family history of type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2005 90 6418-6423. (doi:10.1210/jc.2005-0228)
24. Efstratiadis G, Tsiaousis G, Athyros V.G., Karagianni D., Pavlitou-Tsiontsi A, Giannakou-Darda A & Manes C. Total serum insulin-like growth factor-1 and C-reactive protein in metabolic syndrome with or without diabetes. Angiology 2006 57 303-311. (doi:10.1177/000331970605700306)
25. Maggio M, Lauretani F, Ceda G.P., Bandinelli S., Basaria S, Ble A, Egan J., Paolisso G, Najjar S, Jeffrey Metter E et al. Association between hormones and metabolic syndrome in older Italian men. Journal of the American Geriatrics Society 2006 54 1832-1838. (doi:10.1111/j.1532-5415.2006.00963.x)
26. Maggio M, Lauretani F, Ceda G.P., Bandinelli S., Basaria S, Paolisso G, Ble A., Egan JM, Metter EJ, Abbatecola AM et al. Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study. American Journal of Physiology. Endocrinology and Metabolism 2007 292 E353-E358. (doi:10.1152/ajpendo.00339.2006)
27. Ceda GP, Dall'Aglio E, Magnacavallo A, Vargas N, Fontana V, Maggio M, Valenti G, Lee PD, Hintz RL & Hoffman AR. The insulin-like growth factor axis and plasma lipid levels in the elderly. Journal of Clinical Endocrinology and Metabolism 1998 83 499-502. (doi:10.1210/jc.83.2.499)
28. Colao A, Di Somma C, Cascella T, Pivonello R., Vitale G, Grasso LFS, Lombardi G & Savastano S. Relationships between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. European Journal of Endocrinology 2008 159 389-397. (doi:10.1530/EJE-08-0201)
29. Gram IT, Norat T, Rinaldi S., Dossus L, Lukanova A, Tehard B., Clavel-Chapelon F, van Gils CH, van Noord PAH, Peeters PHM et al. Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. International Journal of Obesity 2006 30 1623-1631. (doi:10.1038/sj.ijo.0803324)
30. Rajpathak SN, Gunter MJ, Wylie-Rosett J, Ho GYF, Kaplan RC, Muzumdar R, Rohan TE & Strickler HD. The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes/Metabolism Research and Reviews 2009 25 3-12. (doi:10.1002/dmrr.919)
31. Sesti G, Sciacqua A, Cardellini M., Marini MA, Maio R, Vatrano M, Succurro E., Lauro R, Federici M & Perticone F. Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes Care 2005 28 120-125. (doi:10.2337/diacare.28.1.120)
32. Sandhu MS, Heald AH, Gibson J.M., Cruickshank JK, Dunger DB & Wareham NJ. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002 359 1740-1745. (doi:10.1016/S0140-6736(02)08655-5)
33. Succurro E, Arturi F, Grembiale A., Iorio F, Laino I, Andreozzi F., Sciacqua A, Hribal ML, Perticone F & Sesti G. Positive association between plasma IGF1 and high-density lipoprotein cholesterol levels in adult nondiabetic subjects. European Journal of Endocrinology 2010 163 75-80. (doi:10.1530/EJE-10-0113)
34. Maison P, Balkau B, Souberbielle J.C., Cunin P., Vol S, Macquin-Mavier I & Eschwege E. Evidence for distinct effects of GH and IGF-I in the metabolic syndrome. Diabetic Medicine 2007 24 1012-1018. (doi:10.1111/j.1464-5491.2007. 02195.x)
35. Rosen T, Eden S, Larson G., Wilhelmsen L & Bengtsson BA. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinologica 1993 129 195-200. (doi:10.1530/acta.0.1290195)
36. de Boer H., Blok GJ, Voerman H.J., Phillips M & Schouten JA. Serum lipid levels in growth hormone-deficient men. Metabolism 1994 43 199-203. (doi:10.1016/0026-0495(94)90245-3)
37. Nikkila EA & Pelkonen R. Serum lipids in acromegaly. Metabolism 1975 24 829-838. (doi:10.1016/0026-0495(75)90129-8)
38. Bates AS, Van't Hoff W, Jones PJ & Clayton RN. The effect of hypopituitarism on life expectancy. Journal of Clinical Endocrinology and Metabolism 1996 81 1169-1172. (doi:10.1210/jc. 81.3.1169)
39. van Bunderen C.C., van Nieuwpoort IC, Arwert LI, Heymans MW, Franken AAM, Koppeschaar HPF, van der Lely AJ & Drent ML. Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the dutch national registry of growth hormone treatment in adults. Journal of Clinical Endocrinology and Metabolism 2011 96 3151-3159. (doi:10.1210/jc.2011-1215)
40. Munzer T, Harman SM, Sorkin JD & Blackman MR. Growth hormone and sex steroid effects on serum glucose, insulin, and lipid concentrations in healthy older women and men. Journal of Clinical Endocrinology and Metabolism 2009 94 3833-3841. (doi:10.1210/jc.2009-1275)
41. Franco C, Koranyi J, Brandberg J., Lonn L, Bengtsson BK, Svensson J & Johannsson G. The reduction in visceral fat mass in response to growth hormone is more marked in men than in oestrogen-deficient women. Growth Hormone & IGF Research 2009 19 112-120. (doi:10.1016/j.ghir.2008.07.001)
42. Bulow B, Ahren B, Fisker S., Dehlin O, Hagberg B, Jensen E., Svensson T, Samuelsson G & Erfurth EM. The gender differences in growth hormone-binding protein and leptin persist in 80-year-old men and women and is not caused by sex hormones. Clinical Endocrinology 2003 59 482-486. (doi:10.1046/j.1365-2265. 2003.01872.x)
43. Andreassen M, Raymond I, Kistorp C., Hildebrandt P, Faber J & Kristensen LO. IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. European Journal of Endocrinology 2009 160 25-31. (doi:10.1530/EJE-08-0452)
44. Schneider HJ, Klotsche J, Saller B., Bohler S, Sievers C, Pittrow D., Ruf G, Marz W, Erwa W., Zeiher AM et al. Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients. European Journal of Endocrinology 2008 158 153-161. (doi:10.1530/EJE-07-0600)
45. Sattar N, McConnachie A, Shaper A.G., Blauw GJ, Buckley BM, de Craen AJ, Ford I, Forouhi NG, Freeman D.J., Jukema JW et al. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008 371 1927-1935. (doi:10.1016/S0140-6736(08) 60602-9)
46. Kriegsman DM, Penninx BW, van Eijk JT, Boeke AJ & Deeg DJ. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. Journal of Clinical Epidemiology 1996 49 1407-1417. (doi:10.1016/S0895-4356(96)00274-0)
47. Brugts MP, van den Beld AW, Hofland LJ, van der Wansem K, van Koetsveld PM, Frystyk J, Lamberts SWJ & Janssen JAMJ. Low circulating insulin-like growth factor I bioactivity in elderly men is associated with increased mortality. Journal of Clinical Endocrinology and Metabolism 2008 93 2515-2522. (doi:10.1210/jc. 2007-1633)
48. Langsted A, Freiberg JJ & Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation 2008 118 2047-2056. (doi:10.1161/CIRCULATIONAHA.108. 804146)